MedTrace Logo

Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation

NCT02434562 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 73

Last updated 2017-01-25

No results posted yet for this study

Summary

This is a prospective biobank set up to collect serum from patients with disorders associated with changes in androgens, estrogens or sex hormone-binding globulin (SHBG), before and/or after treatment.

Conditions

  • Hypogonadism
  • Estrogens
  • Testosterone
  • Androgens

Interventions

OTHER

Serum (with or without urine) samples

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Dirk Vanderschueren, MD, PhD · UZ Leuven

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2016-09-30
Completion
2016-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02434562 on ClinicalTrials.gov